Tenaya Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:TNYA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -23.11 M-15.61 M-15.6 M-13.94 M-19.23 M -64.39 M Cash from investing activities 22.3 M24.99 M8.86 M-67 K-11 K 33.77 M Cash from financing activities 50.26 M-476 K380 K58.24 M-415 K 57.73 M Free cash flow -23.11 M-15.61 M-15.6 M-13.94 M-19.23 M -64.39 M

News

Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript

Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow (NASDAQ:TNYA) 2026-06-05

Tenaya Therapeutics, Inc. (TNYA) Discusses RIDGE-1 Phase Ib/II Data on TN-401 Gene Therapy for PKP2-Associated ARVC - Slideshow (NASDAQ:TNYA) 2026-05-17

Tenaya Therapeutics, Inc. (TNYA) Reports Q1 Loss, Misses Revenue Estimates

Leerink Partners reiterates Outperform on Tenaya stock at $2

William Blair reiterates Outperform on Tenaya Therapeutics stock

3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts - TipRanks.com

Tenaya’s HDAC6 inhibitor shows promise in DMD muscle studies

Tenaya Therapeutics Stock Jumps After New Alnylam Deal - Alnylam Pharmaceuticals (NASDAQ:ALNY), Tenaya Therapeutics (NASDAQ:TNYA)

Tenaya Therapeutics receives Nasdaq notice on minimum bid price and amends equity plan

Tenaya Therapeutics stock price target lowered to $5 at Canaccord

Tenaya Stock Drops After Announcing $60M Equity Offering - Tenaya Therapeutics (NASDAQ:TNYA)